LKIM
CRL icon

Lawson Kroeker Investment Management’s Charles River Laboratories CRL Stock Holding History

Lawson Kroeker Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.35M Sell
28,004
-530
-2% -$94.4K 1.76% 24
2026
Q1 		$4.92M Sell
28,534
-3,104
-10% -$576K 1.43% 26
2025
Q4 		$6.31M Sell
31,638
-18,277
-37% -$3.32M 1.88% 22
2025
Q3 		$7.81M Sell
49,915
-558
-1% -$88.6K 1.43% 22
2025
Q2 		$7.66M Sell
50,473
-5,518
-10% -$736K 1.42% 24
2025
Q1 		$8.43M Buy
55,991
+954
+2% +$160K 1.56% 22
2024
Q4 		$10.2M Sell
55,037
-1,498
-3% -$289K 1.91% 18
2024
Q3 		$11.1M Buy
56,535
+1,077
+2% +$224K 2.03% 16
2024
Q2 		$11.5M Buy
55,458
+300
+0.5% +$68K 2.21% 14
2024
Q1 		$14.9M Sell
55,158
-163
-0.3% -$38.9K 2.83% 10
2023
Q4 		$13.1M Sell
55,321
-13
-0% -$2.56K 2.68% 12
2023
Q3 		$10.8M Buy
55,334
+172
+0.3% +$35.3K 2.39% 13
2023
Q2 		$11.6M Buy
55,162
+223
+0.4% +$44.4K 2.78% 11
2023
Q1 		$11.1M Buy
+54,939
New +$12.5M 2.49% 10

Other funds holding CRL

CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
JPMIA
J.P. Marvel Investment Advisors Boston, Massachusetts $871M AUM 64.45% 1-Year Est. Return

Lawson Kroeker Investment Management's CRL Position: Q2 2026 in Review

Lawson Kroeker Investment Management reduced its Charles River Laboratories (CRL) stake by 1.9% in Q2 2026, selling an estimated $94.4K and leaving 28,004 shares worth $6.35M. The position accounts for 1.76% of the portfolio, ranked #24.

Lawson Kroeker Investment Management first reported a position in CRL in Q1 2023 and has held it in 14 quarters since. The position peaked at $14.9M in Q1 2024. 173 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Lawson Kroeker Investment Management held 28,004 shares of Charles River Laboratories worth $6.35M as of Q2 2026.
  • Lawson Kroeker Investment Management sold 530 Charles River Laboratories shares in Q2 2026, an estimated $94.4K.
  • Charles River Laboratories made up 1.76% of Lawson Kroeker Investment Management's portfolio in Q2 2026, its #24 holding.
  • Lawson Kroeker Investment Management first reported a position in Charles River Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Lawson Kroeker Investment Management's Charles River Laboratories position peaked at $14.9M in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Lawson Kroeker Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.